Published in Neuropsychopharmacology on December 01, 1987
Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A (1994) 1.58
Effects of melatonin administration on daytime sleep after simulated night shift work. J Sleep Res (2001) 0.94
The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J (2014) 0.91
Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci (2014) 0.85
Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res (2014) 0.81
Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology. Sleep Med Clin (2015) 0.79
Has adult sleep duration declined over the last 50+ years? Sleep Med Rev (2015) 0.76
Melatonin supplementation in patients with complete tetraplegia and poor sleep. Sleep Disord (2013) 0.75
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry (1984) 4.72
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet (1990) 4.62
Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol (1990) 3.73
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Light suppresses melatonin secretion in humans. Science (1980) 3.45
Cholera control. Lancet (1994) 3.38
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin. J Clin Microbiol (1980) 3.30
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol (1990) 3.21
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis (1984) 3.07
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res (1997) 2.85
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Assembling a clock for all seasons: are there M and E oscillators in the genes? J Biol Rhythms (2001) 2.62
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis (1988) 2.57
A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry (2001) 2.32
Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet (1987) 2.32
Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20
Intestinal antibody responses after immunisation with cholera B subunit. Lancet (1982) 2.13
Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03
Manic-depressive patients may be supersensitive to light. Lancet (1981) 1.91
Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry (1989) 1.89
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
Sleepwalking associated with zolpidem. J Clin Psychopharmacol (1994) 1.87
Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J Clin Microbiol (1987) 1.82
Oral hydration rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution. Lancet (1978) 1.78
The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76
Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis (1988) 1.76
Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75
Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea. Vaccine (1989) 1.73
ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J Infect Dis (1989) 1.66
An overview of chronic fatigue syndrome. J Clin Psychiatry (1991) 1.65
Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. J Med Microbiol (2009) 1.64
Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull World Health Organ (1984) 1.62
Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. J Clin Microbiol (1989) 1.58
Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA (1995) 1.58
Disturbances of appetite and weight regulation in seasonal affective disorder. Ann N Y Acad Sci (1987) 1.56
Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry (1987) 1.55
One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Diagn Lab Immunol (2003) 1.54
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area. Bull World Health Organ (1981) 1.54
Rates of seasonal affective disorder in children and adolescents. Am J Psychiatry (1995) 1.48
B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J Infect Dis (1987) 1.47
Exaggerated sensitivity to an organophosphate pesticide. Am J Psychiatry (1991) 1.46
Seasonality and affective illness. Am J Psychiatry (1989) 1.44
Plasma leptin in men and women with seasonal affective disorder and in healthy matched controls. Horm Metab Res (2005) 1.42
Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia. Can J Microbiol (1991) 1.40
Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder. J Clin Psychiatry (1997) 1.40
Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine (1996) 1.39
Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, and V. cholerae in children. J Pediatr (1981) 1.39
Sunlight-induced propagation of the lysogenic phage encoding cholera toxin. Infect Immun (2000) 1.38
The phototherapy light visor: more to it than meets the eye. Am J Psychiatry (1995) 1.38
Prevalence of sputum smear-positive tuberculosis in a rural area in Bangladesh. Epidemiol Infect (2006) 1.37
The flower pot technique of rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav (1975) 1.36
Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry (1979) 1.33
Rotavirus infections and climate variability in Dhaka, Bangladesh: a time-series analysis. Epidemiol Infect (2007) 1.33
Immunobead enzyme-linked immunosorbent assay for quantitating immunoglobulin A in human secretions and serum. Infect Immun (1980) 1.32
Biotype as determinant of natural immunising effect of cholera. Lancet (1991) 1.32
Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. J Clin Microbiol (2001) 1.32
Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh. J Clin Microbiol (1999) 1.30
Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics (1998) 1.29
Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis (1991) 1.29
Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am J Psychiatry (1982) 1.28
Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Clin Diagn Lab Immunol (2001) 1.28
Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun (2001) 1.27
Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry (1988) 1.25
Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res (1990) 1.25
Congo red binding and salt aggregation as indicators of virulence in Shigella species. J Clin Microbiol (1988) 1.24
Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine (2009) 1.22
Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol (1991) 1.22
Nutritional and metabolic adaptations to prolonged sleep deprivation in the rat. Am J Physiol (1993) 1.22
Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. BMJ (1989) 1.21
An oral B subunit: whole cell vaccine against cholera. Vaccine (1992) 1.20
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Sleeping pills, insomnia and medical practice. N Engl J Med (1979) 1.20
Sleep apnea syndrome in chronic renal disease. Am J Med (1989) 1.20
The experience of insomnia and daytime and nighttime functioning. Psychiatry Res (1984) 1.19
Relationship between sleep and mood in patients with rapid-cycling bipolar disorder. Psychiatry Res (1996) 1.19